VCEL - Vericel Corporation
| Previous Close | 17.10 |
| Open | 17.28 |
| Bid | 17.17 x 1000 |
| Ask | 17.19 x 1100 |
| Day's Range | 17.02 - 17.61 |
| 52 Week Range | 4.45 - 18.87 |
| Volume | 186,837 |
| Avg. Volume | 1,033,415 |
| Market Cap | 743.19M |
| Beta (3Y Monthly) | 6.62 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.34 |
| Earnings Date | Nov 6, 2017 - Nov 10, 2017 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 21.10 |
- GlobeNewswire•6 hours ago
New Research Coverage Highlights Verisk Analytics, Fortinet, Dine Brands Global, Oppenheimer, Vericel, and Century Communities — Consolidated Revenues, Company Growth, and Expectations for 2018
NEW YORK, Dec. 14, 2018 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.
- American City Business Journals•3 days ago
The Bay State's biggest stock gainer in 2018 is a marijuana company
In 2018, a small, Norwood-based firm in the burgeoning field of marijuana is likely to assume the title of best-performing publicly traded company in Massachusetts — by a wide margin.
Zacks•4 days agoHas Vericel (VCEL) Outpaced Other Medical Stocks This Year?
Is (VCEL) Outperforming Other Medical Stocks This Year?
- Simply Wall St.•10 days ago
Vericel Corporation’s (NASDAQ:VCEL) Path To Profitability
Vericel Corporation's (NASDAQ:VCEL): Vericel Corporation, a commercial-stage biopharmaceutical company, researches, develops, manufactures, markets, and sells patient-specific expanded cellular therapies to repair and regenerate damaged tissues and organs. With the latest Read More...
- Zacks•11 days ago
Small-Cap ETFs & Stocks to Outperform This Holiday Season (Revised)
The outperformance of the small-caps seems to hold true this year given that these pint-sized stocks are well insulated from international headwinds.
- Zacks•14 days ago
Zacks.com highlights: Helen of Troy, Vericel, Mobile Mini and Logitech International
Zacks.com highlights: Helen of Troy, Vericel, Mobile Mini and Logitech International
- Zacks•15 days ago
4 Best Stocks to Buy for Superb Earnings Acceleration
Studies have shown that a majority of successful stocks had seen acceleration in earnings before an uptick in the stock price.
- Zacks•15 days ago
The Zacks Analyst Blog Highlights: Vericel, Malibu Boats, Upland Software, QuinStreet and eGain
The Zacks Analyst Blog Highlights: Vericel, Malibu Boats, Upland Software, QuinStreet and eGain
- Zacks•15 days ago
Zacks.com highlights: Vericel, Mitek, Vanda Pharmaceuticals, Mosaic and Spirit Airlines
Zacks.com highlights: Vericel, Mitek, Vanda Pharmaceuticals, Mosaic and Spirit Airlines
- Zacks•16 days ago
Small-Cap ETFs & Stocks to Outperform This Holiday Season
The outperformance of the small-caps seems to hold true this year given that these pint-sized stocks are well insulated from international headwinds.
- Zacks•16 days ago
5 Stocks With Recent Price Strength to Strengthen Portfolio
Investors target stocks that have been on a bullish run lately. Actually, stocks seeing price strength have a high chance of carrying the momentum forward.
- Thomson Reuters StreetEvents•25 days ago
Edited Transcript of VCEL earnings conference call or presentation 6-Nov-18 1:30pm GMT
Q3 2018 Vericel Corp Earnings Call
- American City Business Journals•last month
Cell therapy biotech Vericel eyes $2B knee repair market
While a competitor stumbles, Cambridge-based cell therapy biotech Vericel Corp. recently saw its share hit a new high after the company announced that its knee cartilage regeneration product could help far more patients than originally thought.
- ACCESSWIRE•last month
Today’s Research Reports on Stocks to Watch: Vericel and OncoSec Medical
NEW YORK, NY / ACCESSWIRE / November 7, 2018 / Vericel Corporation, a commercial-stage biopharmaceutical company, that researches, develops, manufactures, markets, and sells patient-specific expanded cellular ...
- GuruFocus.com•last month
US Market Indexes Close With Gains Tuesday, Dow Up 0.68%
Large-cap indexes post second day of consecutive closing gains
- GlobeNewswire•last month
Vericel Reports Record Third Quarter Revenues of $22.5 Million and Raises Full Year 2018 Revenue Guidance
58% Revenue Growth Over Third Quarter 2017 Conference Call Today at 8:30am Eastern Time CAMBRIDGE, Mass., Nov. 06, 2018 -- Vericel Corporation (NASDAQ:VCEL), a leader in.
- Benzinga•last month
Q3 Earnings Preview For Vericel
Vericel (NASDAQ: VCEL ) will be releasing its next round of earnings this Tuesday, Nov. 6. For all of the relevant information, here is your guide for the Q3 earnings announcement. Earnings and Revenue ...
- GlobeNewswire•last month
Vericel to Present at the Canaccord Genuity Medical Technologies & Diagnostic Forum
CAMBRIDGE, Mass., Nov. 01, 2018 -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced cell therapies for the sports medicine and severe burn care markets, today announced.
- Zacks•last month
Will Vericel (VCEL) Report Negative Earnings Next Week? What You Should Know
Vericel (VCEL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- GlobeNewswire•2 months ago
Vericel to Report Third-Quarter 2018 Financial Results on November 6, 2018
CAMBRIDGE, Mass., Oct. 23, 2018 -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced cell therapies for the sports medicine and severe burn care markets, today announced.
- Simply Wall St.•2 months ago
Should You Worry About The Vericel Corporation’s (NASDAQ:VCEL) Shareholder Register?
Every investor in Vericel Corporation (NASDAQ:VCEL) should be aware of the most powerful shareholder groups. Insiders often own a large chunk of younger, smaller, companies while huge companies tend to Read More...
- Zacks•2 months ago
Zacks Market Edge Highlights: Intuitive Surgical, BioTelemetry, Edwards Lifesciences, Penumbra and Vericel
Zacks Market Edge Highlights: Intuitive Surgical, BioTelemetry, Edwards Lifesciences, Penumbra and Vericel
- Zacks•2 months ago
How to Invest in the Hot Medical Device Innovators
Forget the biotechs. Medical device companies are innovating in amazing ways. Here's how to invest.
